文献速递骨肌MR

T1 与 T2* 定量成像评估肌腱组织生物物理特性:一项体模 MRI 研究

T1- and T2*-Mapping for Assessment of Tendon Tissue Biophysical Properties: A Phantom MRI Study.
PubMed 文献 · Invest Radiol · 2019-01-01

研究在 24 条牛屈肌腱离体模型上,用 3 T MRI 于化学修饰前后行 T1 与 T2* 定量成像,以组织病理学为参考标准。结果显示 T2* 值在酶性降解、交联与对照组间有显著差异,且与肌腱力学特性相关(r=-0.74,P<0.01);T1 值与常规视觉评估无法区分交联与对照组。作者认为 T2* 定量成像有潜力检出常规临床 MRI 不可见的肌腱胶原结构细微变化,T2* 值可能作为肌腱病理相关生化改变的生物标志物。

要点

  • T2* 值可区分酶性降解、胶原交联与对照肌腱,T1 值不能区分交联与对照。
  • T2* 值与肌腱力学特性显著相关(r=-0.74,P<0.01)。
  • 常规 T1/T2 加权视觉评估无法识别交联肌腱的细微改变。

核心结论

  • T2* 定量成像有潜力检出并量化常规临床 MRI 不可见的肌腱胶原结构细微变化,T2* 值可能作为肌腱病理相关生化改变的生物标志物。

研究设计与样本

  • 离体牛屈肌腱模型研究,共 24 条尸体牛屈肌腱,在 3 T MRI 上于化学修饰前后成像,分为胶原降解组、胶原纤维交联增强组与磷酸盐缓冲液对照组,以组织病理学为参考标准,并评估生物力学特性。

关键影像表现/征象

  • T1 与 T2* 定量成像在未处理与处理肌腱上可行且可重复,未处理肌腱均值分别为 545 毫秒与 2.0 毫秒。
  • 胶原降解组、交联组与对照组的 T1 均值分别为 1459、934 与 1017 毫秒,T2* 均值分别为 5.5、3.6 与 2.5 毫秒。
  • T2* 值在酶性降解肌腱、交联肌腱与对照之间均有显著差异,且与肌腱力学特性显著相关(r=-0.74,P<0.01)。
  • T1 值与常规视觉评估无法区分交联组与对照组肌腱。
  • 光谱检查显示交联肌腱自发荧光增加,组织病理学证实酶性降解肌腱存在退行性病变。

诊断标准与关键数值

  • T2* 值:胶原降解组 5.5 毫秒、交联组 3.6 毫秒、对照组 2.5 毫秒,三组间有显著差异。
  • T1 值:胶原降解组 1459 毫秒、交联组 934 毫秒、对照组 1017 毫秒,交联组与对照组无法区分。
  • 未处理肌腱 T1 均值 545 毫秒、T2* 均值 2.0 毫秒。

临床应用与阅片要点

  • 作者认为 T2* 定量成像有潜力检出常规临床 MRI 不可见的肌腱胶原结构细微变化。
  • 作者认为肌腱 T2* 值可能作为肌腱病理相关生化改变的生物标志物。
  • T1 值与常规视觉评估无法区分交联与对照肌腱。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: The aim of this study was to quantitatively assess changes in collagen structure using MR T1- and T2*-mapping in a novel controlled ex vivo tendon model setup.

MATERIALS AND METHODS: Twenty-four cadaveric bovine flexor tendons underwent MRI at 3 T before and after chemical modifications, representing mechanical degeneration and augmentation. Collagen degradation (COL), augmenting collagen fiber cross-linking (CXL), and a control (phosphate-buffered saline [PBS]) were examined in experimental groups, using histopathology as standard of reference. Variable echo-time and variable-flip angle gradient-echo sequences were used for T2*- and T1-mapping, respectively. Standard T1- and T2-weighted spin-echo sequences were acquired for visual assessment of tendon texture. Tendons were assessed subsequently for their biomechanical properties and compared with quantitative MRI analysis.

RESULTS: T1- and T2*-mapping was feasible and repeatable for untreated (mean, 545 milliseconds, 2.0 milliseconds) and treated tendons. Mean T1 and T2* values of COL, CXL, and PBS tendons were 1459, 934, and 1017 milliseconds, and 5.5, 3.6, and 2.5 milliseconds, respectively. T2* values were significantly different between enzymatically degraded tendons, cross-linked tendons, and controls, and were significantly correlated with mechanical tendon properties (r = -0.74, P < 0.01). T1 values and visual assessment could not differentiate CXL from PBS tendons. Photo-spectroscopy showed increased autofluorescence of cross-linked tendons, whereas histopathology verified degenerative lesions of enzymatically degraded tendons.

CONCLUSIONS: T2*-mapping has the potential to detect and quantify subtle changes in tendon collagen structure not visible on conventional clinical MRI. Tendon T2* values might serve as a biomarker for biochemical alterations associated with tendon pathology.

来源:Invest Radiol,查看原文。版权归原作者所有。

引用

  1. Bachmann E, Rosskopf AB, Götschi T, et al. T1- and T2*-Mapping for Assessment of Tendon Tissue Biophysical Properties: A Phantom MRI Study. Invest Radiol. 2019. PMID: 30444794. doi:10.1097/RLI.0000000000000532

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。